Summary
Mrs. Monika Engelhardt is a highly accomplished senior physician and clinical researcher in hematology, oncology, and stem cell transplantation. With decades of experience in both clinical practice and translational research, she plays a pivotal role in multiple myeloma (MM) care, clinical trials, and guideline development at the Universitätsklinikum Freiburg. She is known for her leadership in clinical research, particularly in MM and GCP, and for her active collaboration in European myeloma networks.
 Education
-
Habilitation in Innere Medizin, Universitätsklinikum Freiburg (2002)
-
Apl. Professorin, UKF/CCCF (seit 2005)
-
Fachärztin für Innere Medizin, Hämatologie, Onkologie & Palliativmedizin (2001, 2006, 2009)
Professional Experience
-
Oberärztin & Sektionsleiterin für Klinische Forschung, GCP & Myelomzentrum, UKF/CCCF (seit 2003)
-
Arbeitsgruppenleiterin, Hämatologie & Onkologie, UKF (seit 1997)
-
Postdoctoral Fellow, Memorial Sloan-Kettering Cancer Center, New York (1995–1997)
-
Assistenzärztin, Hämatologie & Onkologie, UKF (1993–2002)
Research Interests
-
Multiple Myeloma (MM)
-
Clinical trial development & GCP studies
-
Translational oncology & biomarker-driven therapies
-
Gender & diversity aspects in precision medicineÂ
-
COVID-19 and hematologic malignancies.